Stocks to buy

Right now, the electric vehicle (EV) industry is riding high on record delivery numbers and positive investor sentiment. True, the industry has suffered in the past few months due to the chip shortage, but it looks like the crunch is nearly over and EV manufacturers are ready to boom. After the IPO in August 2020,

There is absolute clarity on the point that global economic growth is gaining traction. And that means good things for the future of shipping stocks. The international Monetary Fund expects global economic growth at 6% for 2021 and 4.4% for 2022. For the current year, emerging economies are likely to grow at 6.7%. Performance of

From time to time, I find myself perplexed about an opinion I formed on a particular stock. And so I wonder what I was thinking in early June when I lumped The Trade Desk (NASDAQ:TTD) stock in with other bubble stocks? Source: Tada Images / Shutterstock.com In fairness, TTD stock is up 166% since January 2020 making it a pandemic

As we continue to navigate another wild year, one sector that continues to thrive are electric vehicles (EVs). That said, this space shows no signs of slowing down — and that provides a solid outlook for battery stocks. Deloitte estimates suggest that the EV industry will grow at a CAGR of 29% through 2030. That

There’s currently little to suggest that the economy is in any immediate danger of tanking. Well, to be more accurate there are mixed signals in relation to a U.S. economic rebound. Back in June, the U.S. Bureau of Economic Analysis released data indicating that GDP growth reached 6.4% in the first quarter. That was almost

Penn National Gaming (NASDAQ:PENN) produced excellent results for the first quarter, showing that the casino gaming company is now producing free cash flow (FCF). As a result, PENN stock is likely to move significantly higher once the market sees it generate large amounts of cash. Source: Casimiro PT / Shutterstock.com Penn National Gaming has 42

Right now, multiple factors indicate Roku’s (NASDAQ:ROKU) business is growing rapidly. And given the company’s status as a potential takeover target, ROKU stock continues to look very appealing. Source: JHVEPhoto / Shutterstock.com Investors appear to be buying up shares of bigger, more stable tech stocks. The company’s shares have retreated as a result and created

The past two weeks have been monumental for Virgin Galactic Holdings (NYSE:SPCE). Company founder Richard Branson made a successful flight to the edge of space, kicking off the era of billionaires in space, and — much more importantly for investors and SPCE stock — the era of space tourism. Source: Tun Pichitanon / Shutterstock.com Branson’s

Is the move in Virgin Galactic (NYSE:SPCE) ironic or what? Recently, this name exploded higher as the company’s craft took flight, but now SPCE stock is heading back down to Earth, just like the spacecraft. This begs a question: is the price move already over with or is it just beginning?  Source: rafapress / Shutterstock.com

Over the last few months, I’ve generally been bullish on the upside potential of Churchill Capital Corp IV (NYSE:CCIV), the special purpose acquisition company that’s about to merge — barring unusual circumstances — with Lucid Motors, an electric vehicle manufacturer that could potentially challenge competitor in the space Tesla (NASDAQ:TSLA). Admittedly, though, it’s difficult not

In the next few years, the global legal marijuana market is expected to grow at a robust pace. As regulatory headwinds wane, the market size is expected to reach $70.6 billion in 2028. This would imply growth at a CAGR of 26.7%. It’s not surprising that investors have started looking at major marijuana stocks like

Cassava Sciences (NASDAQ:SAVA) announced on July 21 that it would present two new clinical datasets in the upcoming Denver Alzheimer’s conference. The most important of these two will be on July 29 at 11 am ET, when the company releases its nine-month dataset results for its Alzheimer’s drug, Simufilam. Expect to see SAVA stock take

Novavax (NASDAQ:NVAX) looks like good value today given both its prospects (especially in India) and its valuation metrics. This is a biotech company that has developed a popular, non-RNA-related vaccine against Covid-19. Right now, it looks like NVAX stock could be worth at least 100% more to $419 than its present price of $209.52 as

It has been quite a year for Robinhood users. Due to the pandemic, usage of the popular trading app (which is privately owned right now but is preparing for an initial public offering targeted for July 29) skyrocketed among amateur investors. Most of them did not have a lot of experience. But they did have

As all eyeballs focus on the remarkable record-breaking ascent of the major indices, less attention is paid on defensive names. That’s only natural because of immediacy bias or the tendency to perceive current emotions as more intense than previous emotions. Nevertheless, it might be time to think about hedging against this soaring valuation and what

While Elon Musk continues playing with Dogecoin (CCC:DOGE-USD), investors continue to lose money. Down 14% over the past seven days, it’s clear that cryptocurrencies including DOGE-USD are in for one heck of a bear market. When will it end? Who knows. For those who merely want to make money from their investments, here are three

Defensive stocks, which typically have low market risk, are getting increased attention. And these types of shares are popular because they can help protect portfolios from rapid market declines or wild swings in returns. Today, I’ll introduce seven defensive stocks to buy for the earnings season. Despite stomach-churning volatility, especially in the early days of the

Corsair Gaming (NASDAQ:CRSR) is a $2.7 billion market cap gaming console company whose revenue and earnings have been on a tear. That’s great news for investors in CRSR stock. Source: WDphotography / Shutterstock.com Look for this company’s earnings and more importantly, its free cash flow (FCF) to explode higher this year and next as its

Growth has clearly been the winning investment strategy over the past decade. Buying shares of well-managed businesses in industries with above-average growth has proven capable of superior portfolio performance. Therefore today, we’ll discuss seven growth stocks that could be appropriate for a range of InvestorPlace.com readers. Most growth stock have high valuation metrics, such above

By all measures, Clover Health (NASDAQ:CLOV) is having a rough time. Shares have lost roughly 32% of their value in the past month as retail investors on Reddit have set their sights on other targets. But is now the right time to bail on CLOV stock? If you’ve been following the mania this year, there’s